Lithium’s effects on therapeutic targets and MRI biomarkers in Parkinson’s disease: A pilot clinical trial()

BACKGROUND: Lithium has a wide range of neuroprotective actions, has been effective in Parkinson’s disease (PD) animal models and may account for the decreased risk of PD in smokers. METHODS: This open-label pilot clinical trial randomized 16 PD patients to “high-dose” (n = 5, lithium carbonate titr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guttuso, Thomas, Shepherd, Rachel, Frick, Luciana, Feltri, M. Laura, Frerichs, Valerie, Ramanathan, Murali, Zivadinov, Robert, Bergsland, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196787/
https://www.ncbi.nlm.nih.gov/pubmed/37215748
http://dx.doi.org/10.1016/j.ibneur.2023.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196787/
https://www.ncbi.nlm.nih.gov/pubmed/37215748
http://dx.doi.org/10.1016/j.ibneur.2023.05.001

Ejemplares similares